LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.07 | 21.74 | 1044 | 597 | 1.7462 | 1.2473 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.95 | 21.74 | 1508 | 1354 | 1.1133 | 1.0363 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.19 | 21.74 | 127 | 439 | 0.2887 | 0.5020 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 14.10 | 21.74 | 1062 | 540 | 1.9633 | 1.3132 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.01 | 21.74 | 1272 | 901 | 1.4103 | 1.1321 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.98 | 21.74 | 1447 | 1108 | 1.3055 | 1.0963 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.21 | 21.74 | 813 | 392 | 2.0740 | 1.3821 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.16 | 21.74 | 946 | 463 | 2.0404 | 1.3506 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 14.10 | 21.74 | 834 | 540 | 1.5418 | 1.1957 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.04 | 21.74 | 1215 | 750 | 1.6188 | 1.1977 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.04 | 21.74 | 1267 | 750 | 1.6880 | 1.2158 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 20.01 | 21.74 | 1337 | 901 | 1.4824 | 1.1520 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.98 | 21.74 | 1413 | 1108 | 1.2749 | 1.0875 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 2.24 | 21.74 | 609 | 183 | 3.3175 | 1.9528 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.24 | 21.74 | 719 | 317 | 2.2625 | 1.4698 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.21 | 21.74 | 5 | 392 | 0.0128 | -0.2969 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 8.19 | 21.74 | 915 | 439 | 2.0802 | 1.3678 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 10.16 | 21.74 | 455 | 463 | 0.9814 | 0.9915 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.13 | 21.74 | 626 | 496 | 1.2612 | 1.1055 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.13 | 21.74 | 998 | 496 | 2.0106 | 1.3348 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.07 | 21.74 | 1158 | 597 | 1.9369 | 1.2966 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 25.92 | 21.74 | 1554 | 1515 | 1.0253 | 1.0082 | MN20160310_N01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.95 | 21.74 | 1542 | 1354 | 1.1384 | 1.0440 | MN20160310_N01 | C03 |